A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
Kael Wherry, PhD
Advertisement
Articles by Kael Wherry, PhD
Advertisement
Latest Updated Articles
Cost-Effectiveness of the MiniMed 780G System for Type 1 DiabetesPublished: April 10th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
4
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
5
